Results 21 to 30 of about 12,657,081 (210)

Non-responsiveness to hepatitis-B vaccination: revaccination and immunogenetic typing [PDF]

, 1988
Krämer A, Herth D, von Keyserlingk H, et al. Non-responsiveness to hepatitis-B vaccination: revaccination and immunogenetic typing. Klinische Wochenschrift.
Sommer, D., Ludwig, W. D., Hampl, Hartmut, Riecken, Ernst-Otto, Krämer, Alexander ; https://orcid.org/, Hahn, E. G., von Keyserlingk, H., Herth, D.   +7 more
core   +1 more source

Sero-prevalence and risk factors for hepatitis B virus infection among health care workers in a tertiary hospital in Uganda. [PDF]

, 2010
BACKGROUND: Hepatitis B virus (HBV) infection is a global public health challenge. Prevalence of current hepatitis B virus infection in the general population in Uganda is about 10%.
Bwogi, Josephine, Abdhalah K Ziraba, Ziraba, Abdhalah K, Wainaina Caroline W, Mayanja-Kizza Harriet, Josephine Bwogi, Alice Namale, Namale Alice, Ziraba Abdhalah K, Harriet Mayanja-Kizza, Namale, Alice, Caroline W Wainaina, Bwogi Josephine, Mayanja-Kizza, Harriet, Wainaina, Caroline W   +14 more
core   +2 more sources

Research progress of hepatitis B virus and its vaccine [PDF]

BIO Web of Conferences
Hepatitis B is a serious worldwide public health problem with a very high incidence. It is caused by the hepatitis B virus (HBV), and vaccination is the primary preventive measure. However, vaccine non-response or weak immune responses remain a challenge.
Huang Zhenghuai
doaj   +1 more source

Barriers to and Facilitators of Hepatitis B Vaccination among the Adult Population in Indonesia: A Mixed Methods Study

Vaccines, 2023
To reach the goals of the Global Hepatitis Elimination 2030 program, Indonesia is now preparing a new regulation for hepatitis B vaccinations for adult population.
Putri Bungsu Machmud, Amand Führer, Cornelia Gottschick, Rafael Mikolajczyk   +3 more
doaj   +1 more source

Safety and Preliminary Immunogenicity of Recombinant Hepatitis B (Bio Farma) Vaccine in Adults and Children: A Phase 1 Clinical Trial

Althea Medical Journal, 2023
Background: In order to fulfil the requirements of the national immunization program and sustain the production capacity of the monovalent Hepatitis B vaccine, this study aimed to assess the safety and immunogenicity of the recombinant Hepatitis B ...
Eddy Fadlyana, Rodman Tarigan, Kusnandi Rusmil, Rini Mulia Sari, Cissy B Kartasmita, Behesti Zahra Mardiah, Muhammad Gilang Dwi Putra   +6 more
doaj   +1 more source

Influences of obesity on the immunogenicity of Hepatitis B vaccine

Human Vaccines & Immunotherapeutics, 2017
Objective: Hepatitis B vaccine is regarded as the most effective method for the prevention of hepatitis B virus (HBV) infection. However, several factors such as age, body mass index and immunocompetent state have been reported to be associated with ...
Fang Liu, Zhirong Guo, Chen Dong
doaj   +1 more source

Hepatitis A, B, and A/B vaccination series completion among US adults: A claims-based analysis

Human Vaccines & Immunotherapeutics, 2018
Hepatitis A and B disease burden persists in the US. We assessed hepatitis A and hepatitis B vaccination series completion rates among 350,240 commercial/Medicare and 12,599 Medicaid enrollees aged ≥19 years.
Parinaz K. Ghaswalla, Brandon J. Patterson, Wendy Y. Cheng, Emilie Duchesneau, Monica Macheca, Mei Sheng Duh   +5 more
doaj   +1 more source

Timing of the First Dose of the Hepatitis B Vaccine in Preterm Infants

Vaccines, 2022
Introduction: The World Health Organization (WHO) recommends all newborn infants receive the first dose of the hepatitis B vaccine within 24 h of birth irrespective of maternal hepatitis B carrier status.
Donna Lei, Taryn Miller, Jeremy Carr, Jim Buttery, Claudia A. Nold-Petry, Marcel F. Nold, Atul Malhotra   +6 more
doaj   +1 more source

Modelling alternative strategies for delivering hepatitis B vaccine in prisons : the impact on the vaccination coverage of the injecting drug user population [PDF]

, 2008
Since 2001 hepatitis B vaccination has been offered to prisoners on reception into prisons in England and Wales. However, short campaigns of vaccinating the entire population of individual prisons have achieved high vaccination coverage for limited ...
Sutton, AJ, Edmunds, W. John, Gay, NJ, Edmunds, WJ, Gill, ON, Gay, N. J., Sutton, A. J., Gill, O. N., Sutton, Andrew   +8 more
core   +1 more source

Timing of Hepatitis B Vaccine Birth Dose in Exposed Newborns, Southwest Ethiopia: A Cross-Sectional Study

SAGE Open Nursing, 2023
Introduction Hepatitis B virus disease is a global acute and chronic communicable disease. Mother-to-child transmission is the reason for high carrier rates.
Mebratu Demissie MSc, Haregwa Asnake Weldekidan MSc, Yirgalem Yosef MSc, Seboka Abebe Sori MSc, Daniel Tsega MSc, Hirut Dinku Jiru MSc, Aberash Beyene Derribow MSc, Mesfin Difer Tetema MSc, Gudeta Beriso Jima MSc, Fentahun Temene Zeleke MSc, Fikremariam Endeshew MSc, Seblework Abeje MSc   +11 more
doaj   +1 more source